167 related articles for article (PubMed ID: 10342530)
1. Screening for neuroblastoma and age-specific incidence.
Moe PJ
Acta Paediatr; 1999 Apr; 88(4):362-4. PubMed ID: 10342530
[No Abstract] [Full Text] [Related]
2. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
Murphy SB; Cohn SL; Craft AW; Woods WG; Sawada T; Castleberry RP; Levy HL; Prorok PC; Hammond GD
Lancet; 1991 Feb; 337(8737):344-6. PubMed ID: 1671243
[No Abstract] [Full Text] [Related]
3. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
4. Screening for neuroblastoma.
Lancet; 1987 Nov; 2(8569):1204. PubMed ID: 2890821
[No Abstract] [Full Text] [Related]
5. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
Woods WG; Tuchman M; Lemieux B
Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
[No Abstract] [Full Text] [Related]
6. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
7. Mass screening for neuroblastoma in infants.
Wei M; Ye M; Dong K; Dong R
Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
[TBL] [Abstract][Full Text] [Related]
8. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
[TBL] [Abstract][Full Text] [Related]
9. Mass screening for neuroblastoma in Japan.
Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
[TBL] [Abstract][Full Text] [Related]
10. Screening for neuroblastoma (NB) in North America: the Quebec Project.
Woods WG; Lemieux B; Leclerc JM; Bernstein ML; Brisson L; Brossard J; Brodeur GM; Look AT; Robison LL; Shuster JJ
Prog Clin Biol Res; 1994; 385():377-82. PubMed ID: 7972234
[No Abstract] [Full Text] [Related]
11. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
Lamedica G; Falcone R; De Bernardi B; Canini S
Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
[No Abstract] [Full Text] [Related]
12. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
[No Abstract] [Full Text] [Related]
13. Mass screening for neuroblastoma and mortality in birth cohorts.
Nishi M; Miyake H; Takeda T; Hanai J; Kikuchi Y; Takasugi N
Int J Cancer; 1997 May; 71(4):552-5. PubMed ID: 9178807
[TBL] [Abstract][Full Text] [Related]
14. Failure to detect dopaminergic neuroblastoma in a mass-screening system.
Naito H; Takeda T; Hanai J
J Pediatr Surg; 1995 Sep; 30(9):1317-8. PubMed ID: 8523234
[TBL] [Abstract][Full Text] [Related]
15. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
Suita S
J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
Schilling FH; Oberrauch W; Schanz F; Treuner J
Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
[No Abstract] [Full Text] [Related]
17. Laboratory techniques and neuroblastoma screening.
Sawada T
Lancet; 1988 Nov; 2(8620):1134-5. PubMed ID: 2903341
[No Abstract] [Full Text] [Related]
18. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
Scriver CR; Gregory D; Bernstein M; Clow CL; Weisdorf T; Dougherty GE; Auray-Blais C; Giguère R; Lemieux B; Laberge C
CMAJ; 1987 May; 136(9):952-6. PubMed ID: 3105859
[TBL] [Abstract][Full Text] [Related]
19. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening.
Seviour JA; McGill AC; Dale G; Craft AW
J Chromatogr; 1988 Nov; 432():273-7. PubMed ID: 3220894
[No Abstract] [Full Text] [Related]
20. Mass screening for neuroblastoma in Miyagi Prefecture.
Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]